Evidence map›Paper›PMID 30445938›Full record

ArticleBMC cancer2018

Solitary pancreatic metastasis of extremity myxoid liposarcoma: a case report and literature review.

Dingding Wang, Jie Wu, Jian Yu, Hong Zhang, Honggang Liu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Dingding WangDepartment of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Jie WuDepartment of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, Shandong, China.
Jian YuDepartment of Oncology, Rizhao Central Hospital, Rizhao, 276800, Shandong, China.
Hong ZhangDepartment of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Honggang LiuDepartment of Pathology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. liuhg1125@163.com.
Beijing Tongren Hospital · CNCapital Medical University · CNPeople’s Hospital of Rizhao · CNQingdao University · CN

Funding

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (CN) ZYLX101814National Natural Science Foundation of China (CN) 81502493
6 · The paper itself

Abstract

backgroundMyxoid liposarcoma has a distinct migration aptitude; however, pancreatic metastasis is rare. CASE PRESENTATION: We report on the case of a 40-year-old female patient who suffered solitary pancreatic metastasis of myxoid liposarcoma and had a right thigh myxoid liposarcoma radical resection 5 years ago. The patient underwent a medial pancreatectomy and pancreaticojejunostomy for solitary pancreatic metastasis of myxoid liposarcoma. After 12 months of disease-free survival, the patient underwent an extended radical resection for the recurrence of the right thigh primary myxoid liposarcoma and received postoperative radiotherapy. Currently, the disease-free survival time after the last operation has been 22 months.

conclusionsWe reviewed the relevant literature and suggest that radical surgery might result in a good prognosis for patients with solitary pancreatic metastasis of myxoid liposarcoma.

Indexed as

AdultDisease-Free SurvivalFemaleHumansLiposarcoma, MyxoidNeoplasm Recurrence, LocalPancreatic NeoplasmsThighMetastasisMyxoid liposarcomaPancreasPancreatectomySarcoma

Identifiers

PMID30445938
PMCPMC6240240
OpenAlexW2900976671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.